Combination Slows Metastatic CRC Progression Better Than Single Immunotherapy

(MedPage Today) -- SAN FRANCISCO -- An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression versus a single drug, according to a randomized study.
Median progression-free survival...